Syros to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022
August 02 2022 - 7:30AM
Business Wire
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development
of medicines that control the expression of genes, today announced
that it will host a live conference call and webcast at 8:30 a.m.
ET on Tuesday, August 9, 2022 to report its second quarter 2022
financial results and provide a corporate update.
To access the live conference call, please dial (833) 636-1323
(domestic) or (412) 902-4279 (international) and refer to the
“Syros Pharmaceuticals Conference Call.” A webcast of the call will
also be available on the Investors & Media section of the Syros
website at www.syros.com. An archived replay of the webcast will be
available for approximately 30 days following the presentation.
About Syros Pharmaceuticals
Syros is redefining the power of small molecules to control the
expression of genes. Based on its unique ability to elucidate
regulatory regions of the genome, Syros aims to develop medicines
that provide a profound benefit for patients with diseases that
have eluded other genomics-based approaches. Syros is advancing a
robust clinical-stage pipeline, including: tamibarotene, a
first-in-class oral selective RARα agonist in RARA-positive
patients with higher-risk myelodysplastic syndrome and acute
myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide in
patients with acute promyelocytic leukemia; and SY-5609, a highly
selective and potent oral CDK7 inhibitor in patients with select
solid tumors. Syros also has multiple preclinical and discovery
programs in oncology and monogenic diseases. For more information,
visit www.syros.com and follow us on Twitter (@SyrosPharma) and
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220802005265/en/
Media: Courtney Solberg Syros Pharmaceuticals
917-698-9253 csolberg@syros.com
Investors: Hannah Deresiewicz Stern Investor Relations,
Inc. 212-362-1200 hannah.deresiewicz@sternir.com
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Apr 2023 to Apr 2024